CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,631,867 | +23.0% | 59,896 | +0.5% | 0.00% | +33.3% |
| Q2 2023 | $1,326,679 | -8.4% | 59,626 | -10.8% | 0.00% | 0.0% |
| Q1 2023 | $1,448,318 | +137.5% | 66,866 | +122.7% | 0.00% | +200.0% |
| Q4 2022 | $609,848 | -67.7% | 30,027 | -59.2% | 0.00% | -80.0% |
| Q3 2022 | $1,889,000 | +82.0% | 73,667 | +68.7% | 0.01% | +66.7% |
| Q2 2022 | $1,038,000 | +5.6% | 43,667 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $983,000 | +13.6% | 43,667 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $865,000 | +0.2% | 43,667 | -0.5% | 0.00% | 0.0% |
| Q3 2021 | $863,000 | -10.6% | 43,873 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $965,000 | -52.3% | 43,873 | -48.4% | 0.00% | -50.0% |
| Q1 2021 | $2,022,000 | -31.2% | 84,992 | -24.3% | 0.00% | -33.3% |
| Q4 2020 | $2,938,000 | +64.0% | 112,294 | +9.1% | 0.01% | +50.0% |
| Q3 2020 | $1,791,000 | +3.5% | 102,924 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,731,000 | +41.4% | 102,924 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $1,224,000 | +109.9% | 102,924 | +113.7% | 0.00% | +300.0% |
| Q4 2019 | $583,000 | -14.4% | 48,163 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $681,000 | +26.8% | 48,163 | 0.0% | 0.00% | +100.0% |
| Q2 2019 | $537,000 | -5.0% | 48,163 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $565,000 | -12.1% | 48,163 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $643,000 | -4.7% | 48,163 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $675,000 | -10.8% | 48,163 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $757,000 | -10.1% | 48,163 | -5.9% | 0.00% | 0.0% |
| Q1 2018 | $842,000 | -4.3% | 51,163 | +5.0% | 0.00% | 0.0% |
| Q4 2017 | $880,000 | +1.7% | 48,713 | +8.7% | 0.00% | 0.0% |
| Q3 2017 | $865,000 | +84.8% | 44,813 | +13.0% | 0.00% | +100.0% |
| Q2 2017 | $468,000 | +80.0% | 39,663 | +67.2% | 0.00% | 0.0% |
| Q1 2017 | $260,000 | +51.2% | 23,728 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $172,000 | +11.7% | 23,728 | 0.0% | 0.00% | – |
| Q3 2016 | $154,000 | +18.5% | 23,728 | 0.0% | 0.00% | – |
| Q2 2016 | $130,000 | +17.1% | 23,728 | 0.0% | 0.00% | – |
| Q1 2016 | $111,000 | -5.9% | 23,728 | 0.0% | 0.00% | – |
| Q4 2015 | $118,000 | 0.0% | 23,728 | -24.1% | 0.00% | – |
| Q3 2015 | $118,000 | +84.4% | 31,261 | +191.6% | 0.00% | – |
| Q2 2015 | $64,000 | +6.7% | 10,721 | 0.0% | 0.00% | – |
| Q1 2015 | $60,000 | +87.5% | 10,721 | 0.0% | 0.00% | – |
| Q4 2014 | $32,000 | +10.3% | 10,721 | 0.0% | 0.00% | – |
| Q3 2014 | $29,000 | -3.3% | 10,721 | 0.0% | 0.00% | – |
| Q2 2014 | $30,000 | -36.2% | 10,721 | 0.0% | 0.00% | – |
| Q1 2014 | $47,000 | +34.3% | 10,721 | 0.0% | 0.00% | – |
| Q4 2013 | $35,000 | +105.9% | 10,721 | 0.0% | 0.00% | – |
| Q3 2013 | $17,000 | -10.5% | 10,721 | 0.0% | 0.00% | – |
| Q2 2013 | $19,000 | – | 10,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |